Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Spondylitis, Ankylosing × Infliximab × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Arthritis, Rheumatoid 7 Melanoma 3 Colitis 3 Carcinoma, Non-Small-Cell Lung 3 Urogenital Neoplasms 2 Lung Neoplasms 2 Inflammatory Bowel Diseases 2 Depressive Disorder, Major 2 Depression 2 Colitis, Ulcerative 2 Vasculitis 1 Takayasu Arteritis 1 Syndrome 1 Stroke 1 Stevens-Johnson Syndrome 1 Spondylitis, Ankylosing 1 Skin Neoplasms 1 Psoriasis 1 Precancerous Conditions 1 Pemphigoid, Benign Mucous Membrane 1 Inflammation 1 Infections 1 Hepatitis C 1 Hematologic Neoplasms 1 Graft vs Host Disease 1 Fatigue 1 Drug-Related Side Effects and Adverse Reactions 1 Depressive Disorder, Treatment-Resistant 1 Cytokine Release Syndrome 1 Crohn Disease 1

Interventions

Adalimumab 4 Etanercept 3 secukinumab 1 golimumab 1 Vaccines 1 Tumor Necrosis Factors 1 Tai Ji 1 Sulfasalazine 1 Standard of Care 1 Saline Solution 1 Practice Guidelines as Topic 1 Methods 1 Meloxicam 1 Interviews as Topic 1 Infliximab 1 Herpes Zoster Vaccine 1 Exercise 1 Etoricoxib 1 Educational Status 1 Early Intervention, Educational 1 Celecoxib 1 Anti-Inflammatory Agents, Non-Steroidal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05379049 2022-05-18

TNF-alpha

University of Sulaimani

Arthritis, Arthritis, Rheumatoid, Spondylitis, Ankylosing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡